We are live on ! Find out more
BP

BCK Partners Portfolio holdings

AUM $207M
1-Year Est. Return 18%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+18%
3 Year Est. Return
+44.58%
5 Year Est. Return
+37.67%
10 Year Est. Return
AUM
$185M
AUM Growth
-$687K
Cap. Flow
-$2.34M
Cap. Flow %
-1.26%
Top 10 Hldgs %
95.81%
Holding
28
New
2
Increased
5
Reduced
15
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 2.16%
2 Healthcare 0.76%
3 Financials 0.54%
4 Consumer Discretionary 0.33%
5 Industrials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
26
Amgen
AMGN
$208B
$216K 0.12%
+660
New +$209K
SPIB icon
27
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$203K 0.11%
6,005
EXEL icon
28
Exelixis
EXEL
$13.3B
-4,920
Closed -$203K

Similar funds

BCK Partners's Q4 2025 Portfolio in Review

As of Q4 2025, BCK Partners held 28 positions worth $185M, down 0.37% from $186M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

BCK Partners's Q4 2025 filing shows 2 new, 5 increased, 15 reduced and 1 closed positions. Its largest new stake was Amgen: 660 shares worth $216K. The largest sale was Vanguard S&P 500 ETF, an estimated $2.3M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, down from 2.4% a quarter earlier, followed by Healthcare and Financials.

  • BCK Partners's largest Q4 2025 buy was Amgen: 660 shares worth $216K.
  • BCK Partners added most to Vanguard Short-Term Corporate Bond ETF in Q4 2025, an estimated $1.48M increase.
  • BCK Partners's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.3M.
  • BCK Partners fully exited Exelixis in Q4 2025, selling an estimated $203K.
  • BCK Partners's ten largest holdings make up 96% of its $185M portfolio in Q4 2025.
  • BCK Partners opened 2 new positions and closed 1 in Q4 2025.
  • BCK Partners's portfolio value fell 0.37% quarter-over-quarter to $185M.

Based on BCK Partners's 13F filing for Q4 2025, filed 28 Jan 2026.